| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Lakefront Biotherapeutics NV a biopharmaceutical company committed to improving the lives of people with severe diseases. It focuses on delivering medicines with transformational impact for patients by accelerating life-changing science and...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Lakefront Biotherapeutics (NASDAQ:LKFT) through any online brokerage.
Other companies in Lakefront Biotherapeutics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Lakefront Biotherapeutics has a consensus price target of $35.50.
The stock price for Lakefront Biotherapeutics (NASDAQ: LKFT) is $31.4 last updated October 22, 2026 at 4:00 PM EDT.
There are no upcoming dividends for Lakefront Biotherapeutics.
Lakefront Biotherapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Lakefront Biotherapeutics.
Lakefront Biotherapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
